Arca Biopharma | ABIO - Trade Creditors


Arca Biopharma reported $6.67M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 20.83B 17.97B Sep/2026
Arca Biopharma USD 6.67M 2.5M Mar/2026
Biogen USD 430.3M 26.4M Sep/2026
Brainstorm Cell Therapeutics USD 7.49M 171K Jun/2026
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
Capricor Therapeutics 3.08M 848.23K Jun/2026
Cipla INR 32.66B 361.1M Sep/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.15M 371K Jun/2026
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 25.96M 5.45M Sep/2026
Daiichi Sankyo JPY 612.24B 73.19B Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Grifols EUR 987.75M 47.87M Dec/2025
Laboratory Of America USD 738M 49.5M Sep/2026
Myriad Genetics USD 30.4M 2.2M Jun/2026
Otsuka Holdings JPY 199.81B 16.83B Sep/2026
Pfizer USD 4.07B 511M Sep/2026
United Therapeutics USD 520.2M 22.4M Sep/2026